A Phase I/II Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GP-2250 in Combination with Gemcitabine in Subjects with Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma Who Have Progressed on Prior Treatment with 5-Fluorouacil-based Chemotherapy

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03854110

Study #:
STUDY00143646

Start Date:
Jul 29, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03854110

View Complete Trial Details & Eligibility at ClinicalTrials.gov